Every famous medical laboratories are in hurry who will going to launch their product for treatment of Covid-19 in India.If we take many other examples such as Hamdard has also started testing its two immunity boosters as it has got all approvals from the government authorities.So the market is being too competitive in nature and its the matter of time when the vaccine will be launching and after that this all immunity boosters will be having tough time than.
Pharma sector major Dr Reddy laboratories have launched its generic drug Remdesivir for Covid-19 treatment in India.The Remdesivir drug will help for the treatment of those people who have severe symptoms and will be available in hospitals for the treatment.It will cost around Rs 5400 for a 100 mg vial.The pharma major has entered into a non-exclusive agreement with Remdesivir innovating company Gilead Sciences Inc of US.The innovator company is going to sell this drug to almost 127 countries including India.
The drug which was originally developed for the treatment of Ebola by the innovator company.In India it has been approved by the Drug Controller General of India.This drug will be available in the brand name of Redyx in India.The company says we will continue to work effortlessly to develop such products that addresses the needs of the patients.They added that launching of Redyx drug will increase the commitment to bringing more such critical medicines for the covid-19 treatment.
The pharma major have already launched Favipiravir 200 mg in the last month under its innovator Avigan in the Indian market following a pact with its innovator Fujifilm of Japan.This drug has been approved by the DCGI for the treatment of patients suffering from mild to moderate symptoms.For this the Fujifilm has granted the rights to Dr Reddy for this division of drugs.
So lets hope that everyone gets treated well and are fit.We want our normal life back soon lets hope for the best.